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Abstract.  Keratin intermediate filaments (IF) are ob- 
ligate heteropolymers containing  equal amounts of 
type I and type II keratin.  We have previously shown 
that microinjected biotinylated type I keratin is rapidly 
incorporated into endogenous bundles of keratin IF 
(tonofilaments) of PtK2 cells. In this  study we show 
that the earliest steps in the assembly of keratin 
subunits into tonofilaments involve the extremely rapid 
formation of discrete aggregates of microinjected kera- 
tin.  These are seen as fluorescent spots containing 
both type I and type II keratins within  1 min post- 
injection as determined by double label immunofluo- 
rescence. These observations suggest that endogenous 
type II keratin subunits can be rapidly mobilized from 
their endogenous state to form complexes with the in- 
jected type I protein.  Furthermore,  confocal micros- 
copy and immunogold electron microscopy suggest 
that the type 1-type II keratin spots form in close as- 
sociation with the endogenous keratin IF network. 
When the biotinylated protein is injected at concentra- 
tions of 0.3-0.5 mg/ml,  the organization  of the endog- 
enous network of tonofilaments remains undisturbed 
during incorporation into tonofilaments.  However, 
microinjection of 1.5-2.0 mg/mi of biotinylated type I 
results in significant alterations  in the organization and 
assembly state of the endogenous keratin IF network 
soon after microinjection.  The results of this study are 
consistent with the existence of a  state of equilibrium 
between keratin subunits and polymerized keratin IF 
in epithelial cells, and provide further proof that IF 
are dynamic elements of the cytoskeleton of mam- 
malian cells. 
PITHELIAL cells contain large bundles of lO-nm-diam 
intermediate  filaments  (IF) ~, termed tonofilaments, 
comprised of heteropolymers of the types I and II IF 
proteins, the keratins.  At the center of the cell tonofilaments 
are associated with the nuclear envelope and nuclear pore 
complexes (32).  These appear to be continuous with tono- 
filaments  radiating  throughout the cytoplasm,  forming  an 
anastomosing  network which at the cell surface interacts 
with  microfilaments  (34)  and  the  plaque  structures  of 
hemidesmosomes and desmosomes (43). The equimolar ra- 
tios of type I and II keratins expressed in vivo are a direct 
consequence of the requirement for heterodimers in the as- 
sembly of keratin IF (15, 37, 74). The two protein chains of 
the heterodimer appear to be aligned parallel and in register 
(63). While the large family of keratins  are often expressed 
as cell specific pairs in vivo (78, 80), keratin IF are formed 
from nearly any combination of the two types in vitro (35). 
In vitro assembly studies  with mutant keratins  (16, 36- 
38), transient transfection  studies  (1, 2, 82), and transgenic 
mouse experiments  (18, 83) have helped to determine which 
domains within the keratin molecule are essential for assem- 
bly of IF.  These studies  have  shown  that  the amino- and 
carboxy-terminal ends of the c~-helical central  rod domain 
1. Abbreviation used in this paper: IF, intermediate filament. 
are important for IF formation  in vitro and in vivo (1, 2, 38, 
53, 54, 82). However, deletion of the non-a-helical end do- 
mains  still results  in IF assembly (1, 2, 36, 54). 
Experiments  designed  to determine the domains within 
the keratin molecule required for de novo keratin IF network 
assembly have utilized  the co-transfection  of type I and II 
keratin genes into cells devoid of keratin.  These experiments 
have produced conflicting results.  Transient  co-transfection 
with both mutant genes lacking  the non-a-helical COOH- 
terminal  domain indicate  that this domain is not necessary 
for IF assembly (4). However, experiments  involving retro- 
viral mediated expression  of a pair of mutant keratins  indi- 
cate that one of the keratins  must contain both the non-c~- 
helical head and tail domains for efficient de novo filament 
formation  to occur (54). 
These studies on assembly are also relevant to the etiology 
of epidermolysis bullosa simplex (17, 24, 51) and epidermo- 
lyric hyperkeratosis (9,  10,  14, 30, 42, 67), blistering  skin 
diseases in  which there  is  disruption  of tonofilament  in- 
tegrity and cytolysis (7, 41). Significantly, point mutations 
within keratin chains have been found in these disease states 
(17, 51, 67) leading to the suggestion that keratin IF may play 
a role in the mechanical  integrity of keratinocytes  within the 
physiological  milieu  of skin  tissue  (7,  9,  10,  17,  18,  24, 
51, 67). 
The prevailing view of IF as relatively  inert cytoskeletal 
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are dynamic cytoskeletal structures  (26, 32, 70,  77). The 
former  notion  was  in  part  based  on  the  low  solubility 
coefficient  of  IF  in  most  neutral  physiological-strength 
buffers in vitro (68), the concept of disulfde bond stabiliza- 
tion of keratin  IF in the epidermal differentiation  process 
(76), the slow rates of IF protein turnover (19, 56), and the 
existence of barely detectable "soluble pools" of IF subunits 
in cell homogenates  (6, 31, 40, 71). Recently, however, evi- 
dence has become available which supports a more dynamic 
model oflE In mitosis, for example, various cell types disas- 
semble their IF and subsequently reassemble them following 
cytokinesis (28, 44, 50, 66). It has been demonstrated that 
the disassembly of both vimentin IF (11, 12) and the nuclear 
lamina (20, 64, 87), are accompanied by hyperphosphoryla- 
tion catalyzed by p34  c.2. In further support of the role of 
phosphorylation  in  the  regulation  of  IF  polymerization 
states, in vitro studies have shown that vimentin and/or des- 
min IF are phosphorylated by several kinases which induce 
disassembly (39, 46) and that protein kinase C appears to be 
closely associated with vimentin (59, 72) and keratin  (62). 
In addition,  the rapid turnover  of phosphate demonstrated 
for vimentin (25) is mediated in part by protein phospha- 
tases whose function is essential  for the structural  integrity 
of vimentin  IF (25). 
Biochemical  approaches have also provided information 
about the IF assembly process. Pulse chase experiments  in- 
dicate that newly synthesized  vimentin  is rapidly incorpo- 
rated into IF networks using either co-translational  (40) or 
posttranslational  mechanisms (6, 40). Interestingly, different 
mesenchymal  cell types may use these two mechanisms  to 
vastly varying extents (6, 40). While the "soluble pool" of IF 
in cells may be extremely  small,  experiments  conducted at 
steady state using fluorescence recovery after photobleach- 
ing techniques  demonstrate that a pool of vimentin IF is in- 
deed kineticaUy active,  allowing  for the rapid exchange of 
vimentin  subunits  along IF fibers (86).  Furthermore,  fluo- 
rescence energy transfer experiments demonstrate that neuro- 
filament  IF  (3)  and  glial  fibrillary  acidic  protein  (60) 
subunits exhibit a dynamic exchange equilibrium with IF in 
vitro and also indicate that a specific dissociation  step may 
be rate limiting (3). Similar information  concerning  the dy- 
namic aspects of keratin IF in epithelial cells is not available. 
Information  concerning  the sites of IF assembly has been 
derived from several lines of experimentation.  In the case of 
keratin IE ajuxtanuclear incorporation  of newly synthesized 
subunits  has  been described following  recovery from the 
effects of transiently  transfected  mutant genes (1, 2). Other 
transfection  studies using vimentin genes suggest that incor- 
poration of newly synthesized  subunits  occurs throughout 
the cell (61, 65). Similarly, microinjection  of keratin mRNA 
demonstrates that de novo network assembly can also occur 
throughout the cytoplasm (29).  Thus,  it seems likely that 
different IF systems may use different processes for the in- 
corporation of their subunits into pre-existing and newly de- 
veloping  IF networks. 
Microinjection techniques have also been employed in de- 
termining the steps in the posttranslational  assembly of kera- 
tin IF (57).  Immediately after injection into either primary 
mouse  epidermal  cells  or  PtK2 cells,  aggregates  of bio- 
tinylated type I keratin  are distributed throughout  the cyto- 
plasm.  Within  minutes,  these aggregates  appear  to  form 
short biotinylated tonofibrils that are coincident with endog- 
enous tonofilaments.  After 2  h  a  continuous biotinylated 
tonofilarnent  network is seen which co-localizes  with the 
endogenous tonofilament network.  These experiments  dem- 
onstrate  that  keratin  subunit  assembly  into  endogenous 
tonofilaments can take place at discrete sites throughout  the 
cytoplasm. The different assembly sites seen when keratin 
is studied following either transfection with keratin genes or 
microinjection  of purified  keratin  may be related  to differ- 
ences in co-translational  or posttranslational  mechanisms 
used by the cell (57, 70). 
Microinjection methods have also been used in studies of 
posttranslational  assembly for other types of IF during inter- 
phase. Upon microinjection  into cultured fibroblasts (84) or 
PtK2 cells (57), vimentin is assembled into the endogenous 
IF network in a juxtanuclear organization  center.  Further- 
more, microinjection  of phosphorylated GFAP suggests that 
the phosphorylation state of the injected protein can affect 
the  temporal  and  spatial  patterns  of incorporation  (88). 
Fluorescent-labeled desmin also incorporates into an IF pat- 
tern (58) and microinjection of the type V IF protein, lamin 
A, results in its rapid incorporation  into the nuclear lamina 
during  interphase  (33).  These observations  indicate that IF 
polymer networks are dynamic with respect to their capacity 
to incorporate additional  structural  subunits. 
These types of studies have provided new information  re- 
garding the sites of assembly of IF and some details of the 
mechanisms  underlying  their  incorporation  into polymer- 
ized  networks.  However,  these  studies  have  not revealed 
much information about the earliest steps in the assembly of 
IF subunits  into their respective polymer systems. Hetero- 
polymer keratin IF provide an advantageous system in which 
to study the early steps in the assembly process because of 
the availability of soluble and injectable biotinylated  type I 
keratin (57) and specific immunological  probes for type II 
keratin subunits (23). The results reported here demonstrate 
that  incorporation  of biotinylated  type I  keratin  involves 
rapid association with an endogenous type II keratin,  before 
formation of tonofilaments.  Furthermore microinjection  of 
high concentrations  of type I keratin results in the alteration 
of the endogenous  keratin network.  These results support a 
dynamic equilibrium model for keratin IF based on a rapidly 
exchangeable  pool of keratin  within  the cell. 
Materials and Methods 
Preparation of ~ype I Keratin 
Biotinylated type I keratin was prepared from  bovine tongue epithelium as 
described elsewhere  (57). Protein  concentrations  for injection were deter- 
mined after dialysis into injection buffer (10 mM Tris, pH 7.4) (57) using 
the method of Bradford (8) with BSA as a standard. Biotinylated bovine type 
II keratin is not soluble under these conditions and we have not found alter- 
hate suitable conditions for its injection. The percentage of type I keratin 
biotinylated in the injection sample was determined using avidin affinity 
column chromatography. 90-95% of the injected protein was biotinylated, 
as determined by densitometric scanning of Coomassie blue-stained gels 
obtained  from bound  vs.  unbound  fractions  of avidin affinity columns 
(Pierce Chemical Co., Rockford, IL).  Unbound protein was shown to be 
non-biotinylated by immunoblotting analysis with goat anti-biotin antibody 
(Sigma Immunochemicals, St. Louis, MO) (data not shown). 
Glutaraldehyde cross-linking studies were carried out to determine the 
oligomeric state of the biotinylated type I keratin. Fresh aliquots of glutaral- 
dehyde (EM grade;  Electron  Microscopy Science,  s,  Fort  Washington, PA) 
were  diluted  to 1.2% in I0  mM  Tris,  pH 7.4,  immediately  before  use.  This 
The Journal of Cell Biology, Volume 122,  1993  124 glutaraldehyde  stock solution was added to 100-/~1  aliquots of type I keratin 
(100 #g/ml) in the same buffer to yield final glutaraldehyde  concentrations 
in the range of 0.1-0.6%.  Samples were mixed by vortexing.  For each con- 
centration of glutaraldehyde,  cross-linking was carried out for 2, 3, 5, 7, 9, 
11,  and  13  rain.  At  appropriate  times,  the cross-linking reaction was 
quenched using an equal volume of SDS-sample buffer containing 0.3% 
BME. As a positive control, vimentin IF subunits were also cross-linked. 
In this case,  a band corresponding in size to tetramers was identified  on 
Coomassie-stained SDS-gels  (Eriksson, J.  E.,  and R.  D. Goldman, per- 
sonal  communication).  Samples  were  analyzed by  SDS-PAGE  and the 
resulting gels were stained with Coomassie brilliant blue R-250 (Sigma Im- 
munochemicals). A single band at 48 kD was observed at all glutaraldehyde 
concentrations and for all times of incubation. No cross linking into higher 
molecular weight forms was seen, indicating that the injected type I keratin 
is monomeric. Non-biotinylated type I bovine tongue keratin was extracted 
and prepared on a DE-52 ion-exchange column exactly as described for bi- 
otinylated keratin (57). 
Cell Culture 
PtK2 cells were grown in MEM (Gibco Laboratories, Grand Island, NY) 
with 10% FCS, penicillin, and streptomycin  as previously described (57). 
For microinjection, these cells  were grown on glass locator coverslips 
(Bellco Glass,  Vineland, N  J). 
PtK2 IF Preparations 
IF were prepared from confluent dishes of PtK2 cells as described else- 
where (90). 
Immunoblotting 
Immunoblotting was carried out by the method of Towbin et al. (81). The 
mAbs, &El and AE3 (23), directed against type I and H keratins, respec- 
tively, were provided by Dr.  T.-T. Sun (New York University College  of 
Medicine, New York) and were used at a dilution of 1:50 as previously  de- 
scribed (57).  Troma 1, a rat mAb directed against mouse keratin 8, was 
provided by Dr. Robert G. Oshima (La Jolla Cancer Research Foundation, 
La Jolla, CA) and was used undiluted.  Goat anti-biotin antibody (Sigma 
Immunochemicals) showed no cross-reacting proteins in immunoblot anal- 
yses of whole-cell extracts and IF preparations obtained from PIK2 cells. 
Peroxidase-conjugated  secondary antibodies included rabbit anti-goat 
(Amersham, Arlington Heights,  IL),  goat anti-rat (Jackson  Immunore- 
search Laboratories, Inc., West Grove, PAL and goat anti-mouse (Southern 
Bioteclmologies  Associates,  Inc., Birmingham, AL), all used at a dilution 
of 1:1,000. 
cence was carried out on cells grown and injected on 2 mmx 4 mm cover- 
slips cut from larger locator coverslips with a diamond edge.  These latter 
preparations were fixed, washed,  and stained in 96-micro-well plates con- 
taining 200  ml  of the  appropriate  solutions.  Cells  were  examined by 
epifluorescence  with a Zeiss Axiophot microscope or a Zeiss Laser Scan 
Microscope (LSM) (Carl Zeiss, Oberkochen, Germany) equipped with a 
488 X argon laser and a 543  )~ helium-neon laser.  Confocal images were 
photographed with a Matrix multicolor high-resolution  monitor (Matrix In- 
struments,  Inc., Orangeberg,  NY) equipped with a 35-mm camera. 
Overlay Analysis of Tonofilaments and Spots 
Containing Biotinylated ~ffTe  I Protein 
PtK2 cells were  injected with biotinylated type I keratin. After 20 rains, 
cells were fixed and stained for double label indirect irmnunofluorescence 
with anti-biotin  and anti-keratin antibodies.  Confocal microscopy  was used 
to obtain both rhodamine and fluorescein images. The brightest  biotinylated 
spots were identified by their visibility through a single sheet of vellum pa- 
per and traced onto clear plastic using an extra-fine Sharpie marker. This 
spot pattern was overlaid onto the endogenous  keratin pattern and aligned 
using the assistance  of the "protect-image" mode of the LSM software. Spots 
were scored as either associated with tonofilaments  or not associated.  Fur- 
thermore, of  those spots associated with tonofilaments,  we also scored those 
in close proximity with apparent branch points in the tonofilament network. 
Immunogold Electron Microscopy 
A procedure modified from Yang et al. (90) was used. Injected cells were 
fixed on locator coverslips in dry methanol (-20°C) for 3 min, and rinsed 
in PBS for 1 rain. Goat anti-biotin (Sigma Immanechemicals) and normal 
donkey serum (Janssen Inc., Olen, Belgim) in cacodylate buffer (0.1 M 
sodium cacodylate  trihydrate,  pH 7.2) (Ted Pella Inc., Redding, CA) were 
applied to the cells for 30 min at 37°C at a dilution of 1:20. Coverslips were 
rinsed three times over 9 rain in cacodylate buffer. Rabbit anti-goat second- 
ary  antibody conjugated  with 5  um gold  particles  (Amersham Corp., 
Arlington Heights,  IL) was used at a 1:5 dilution in cacodylate buffer for 
30 rain at 37°C.  Cells  were rinsed as above  and fixed  for  1 h  in  1% 
glutaraidehydedcacodylate buffer. After three rinses (20-rain each) in caco- 
dylate buffer, cells were postfixed  for 2-6 h in 1% OsO4, 0.8% potassium 
ferricyanide  (K3Fe[CN]6) (Sigma Immunochemicals) in eacodylate buffer 
at 5°C in the dark. Preparations were then counterstained with 1% uranyl 
acetate, dehydrated  in sequential  ethanol baths, and embedded in epon- 
araldite as detailed in an earlier publication (85). Embedded, injected cells 
were removed from the glass coverslip,  and located  via the impression in 
Microinjections 
Microinjections were carried out as previously described (57). Microinjec- 
tions of type I keratin at concentrations >2.0 mg/ml could not be carded 
out.  This was due to clogging  of the tip of the needle.  In control assays, 
biotinylated BSA,  containing 8-10 biotin moieties per molecule (Pierce 
Chemical Co., Rockford, IL), was resuspended in 10 mM Tris, pH 7.4, and 
clarified  at 12,000 g for 2 min before microinjection. 
Indirect Immunofluorescence 
PtK2  cells were  processed  for  indirect immunofluorescence  using cold 
methanol fixation as described elsewhere (57, 90). Alternatively,  cells were 
fixed for 5 rain in 1% formaldehyde/0.5  mM MgCI2/1 mM CaC12/PBS, ex- 
tracted in three washes of 0.1% NP-40/PBS over 5 rain at room temperature, 
and rinsed in PBS for 2 rain before the addition of antibodies (33). This lat- 
ter fixation procedure produced staining results identical to those obtained 
with methanol fixation, except that background mitochondrial staining due 
to  endogenous biotin was  eliminated. Biotinylated  keratin was detected 
using goat anti-biotin antibody (Sigma  Immunochemicals) and donkey 
anti-goat secondary antibody conjugated with ~  (Jackson  Immuno- 
Research Laboratories, Inc., West Grove, PA) as described elsewhere (57, 
85).  Endogenous  keratin networks  were revealed using either Troma 1 or 
a rabbit  polyclonai directed against mouse epidermal type I keratin as previ- 
ously described (45). Another rabbit polyclonal  (#140) raised against type 
II mouse epidermal keratin was used in some experiments to detect the kera- 
tin aggregates which formed soon after microinjection. To monitor the fate 
of microinjected keratin at short time points (30 s to 3 rain), immunofluores- 
Figure  L AE3 antibody recog- 
nizes a type II keratin in PtK2 
cells, but does not react with 
injected type  I  keratin.  AE3 
has been shown to react pri- 
marily  with  type  II  keratin, 
and AE1  with type I  keratin 
(23).  PtK2  IF  (lane A,  SDS- 
PAGE, Coomassie blue) were 
transferred  to  nitrocellulose 
and probed with anti-keratin 8 
(lane B)  AE3  (lane  C),  and 
AE1  (lane  D).  v,  vimentin. 
Previous work by Miller et al. 
(Fig.  2  in  reference  57)  has 
demonstrated  by  immuno- 
blotting  criteria  that  bovine 
tongue type I  keratins do not 
react with AE3 antibody. 
Miller ¢t al. Dynamic Properties of Keratin Intermediate Filaments  125 Figure  2. Type U spots are revealed with AE3 antibody and co- 
localize with biotinylated type I spots in cells injected with type 
I keratin. PtK2  cells were injected with biotinylated type I ker- 
atin. After 2 min (A) or 20 min (B and C), cells were fixed and 
stained for indirect immunofluorescence using AE3 (A and C) 
or anti-biotin (B). Staining of PtK2 cells with AE3 antibody 
shows weak staining of  endogenous keratin IF networks, but not 
the bright spots seen after microinjection. Bar, 10 #m. 
the Epon left by the lceator coverslip (85), sectioned en face, stained, and 
viewed on a  1200EX electron microscope (Jeol Ltd. Tokyo, Japan) as de- 
scribed elsewhere (85). 
the incorporation process with respect to interactions with 
endogenous type II keratin, with which the injected type I 
keratin should pair to form IF (15, 37, 63,  74). 
Results 
Our previous work at the light microscope level of resolution 
showed that microinjected biotinylated type I keratin formed 
discrete spots immediately after microinjection (57). Elon- 
gated "squiggles" of biotinylated keratin were then observed 
in close association with endogenous tonofilaments as the 
spots disappeared. After 2-4 h, a biotinylated keratin IF net- 
work which colocalized with the endogenous keratin net- 
work was seen (57). However, these studies did not examine 
7~jpe H Keratin Rapidly Associates with Microinjected 
T~e I Keratin 
A  characterization of the  antibodies  used  to  analyze the 
earliest steps in the incorporation process was carried out. 
AE1 and AE3 antibodies have been used previously to distin- 
guish type I and II keratins (23). AE1 recognizes type I kera- 
tin and AE3 recognizes type II. In agreement with the work 
of others (22), AE3 antibody did not recognize the injected 
biotinylated type I keratin by immunoblotting criteria (see 
The Journal  of Cell Biology,  Volume 122, 1993  126 Figure 3. Confocal microscopy showing greater detail of the co-localization of type II spots and biotinylated type I spots. PtK~ cells were 
injected with biotinylated type I keratin and fixed after 20 min.  Cells were stained with anti-biotin (A), and AE3 (B). Arrows point to 
examples of individual spots which co-align.  Bar,  10 #m. 
Fig.  2  in reference 57).  Immunoblotting analysis was also 
carried out to confirm the reactivity of AE3 antibody with 
the endogenous type II keratin of PtK~ cells. PtK~ cells have 
been shown to contain primarily keratins K8 and K18 (27). 
AE3 recognized a single band corresponding to K8 (a type 
II) in immunoblotting analyses of both PtK~ IF preparations 
(Fig.  1, lane c) and whole cell extracts (data not shown). 
To determine the speed of association of endogenous type 
II keratin with the injected type I keratin, cells were fixed 
at short time points postinjection and stained with AE3 anti- 
body.  Within  less than  1 min,  a  spot pattern was seen by 
indirect immunofluorescence (Fig.  2 A).  To determine the 
relationship between these spots and the aggregates of bi- 
otinylated type I keratin, double label immunofluorescence 
was carried out. The AE3 pattern was virtually identical to 
that of the biotinylated keratin spot pattern (Fig. 2, B and C). 
Similar results were also obtained using a rabbit polyclonal 
antibody  #140,  see  Materials  and  Methods)  which  recog- 
nized  type II PtK2  keratin,  and  did  not  recognize  the  in- 
jected biotinylated keratin as determined by immunoblotting 
Figure 4. AE3 antibody does not react with injected biotinylated type I keratin in vivo. To show that AE3 antibody does not react with 
injected type I keratin in vivo, biotinylated type I keratin was microinjected  into BHK-21 fibroblasts, which do not contain keratin,  and 
stained after 20 rain with anti-biotin (A) and AE3 (B) antibodies.  Photography  of anti-biotin (fluorescein) used a 30-s exposure,  while 
AE3 (rhodamine) required a 5-min exposure to capture any image on film. After extended time periods after microinjection  (24 h), the 
biotin-spots  are not longer detectable  with antibiotin.  Bar, 20/xm. 
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show the co-incidence of anti-biotin and AE3  staining in 
microinjected cells (Fig. 3, A and B). It should be noted that 
AE3  stained the endogenous keratin IF networks of PtK2 
cells very weakly (Fig. 2, A and C). This was most likely 
due to an epitope masking phenomenon, which has been 
documented previously with AE3 (47) and other keratin an- 
tibodies (28,  89).  In contrast, the appropriate epitope ap- 
peared to be readily available in the spots seen early after 
microinjection. Therefore, most of the AE3 epitopes are 
probably unavailable within the structure of the fully poly- 
merized keratin IF. 
To  demonstrate that the coincidence of anti-biotin and 
AE3 immunofluorescence  patterns was not due to crossreac- 
tivity between AE3 and the injected protein in the in vivo sit- 
uation, the following control was carried out. Biotinylated 
type I keratin (1.0-2.0 mg/ml) was microinjected into BHK-1 
fibroblasts, which do not contain keratin IF by immunologi- 
cal criteria (Miller, R. K., and R. D. Goldman, unpublished 
observations). After 20-30 min, cells were processed in the 
same fashion for indirect immunofluorescence using AE3 
and anti-biotin antibodies. While spots were clearly visible 
with anti-biotin (Fig. 4 A), AE3 exhibited no immunoreac- 
tivity (Fig. 4 B). As an additional control, non-biotinylated 
type I keratin was injected into PtK2 cells and stained with 
AE3 antibody. Spot patterns, identical in appearance, were 
observed at 20 min after injection (data not shown). 
High Concentrations of  Exogenous 1)pc I Keratin 
Induce Structural Alterations in Endogenous Keratin 
IF Networks 
The microinjection results described above suggested that 
the exogenous bovine type I keratin rapidly associated with 
endogenous type II keratin. Since a likely source of the type 
II protein is the polymerized IF comprising the tonofila- 
ments, we decided to determine whether or not higher con- 
centrations of an injected type I keratin would have an effect 
on the structural integrity or extent of polymerization of the 
endogenous keratin IF network.  A  concentrated (1.5-2.0 
mg/ml) solution of biotinylated type I keratin was prepared 
and injected into PtK2 cells.  The endogenous keratin IF 
network was  observed  using the  K8  antibody,  Troma  1. 
Within 1 to 3 h after injection, alterations in the endogenous 
IF networks were observed (Fig. 5, A and B). These altera- 
tions were more pronounced in the peripheral regions of the 
cell, where very few or no continuous tonofilaments could 
be  found.  Normally this  region contains numerous  long 
tonofilaments (see Fig. 5, D and E). The central portion of 
the keratin IF network appeared less affected (Fig. 5, A and 
B). These alterations of the keratin IF network did not result 
in obvious changes in cell shape as determined by phase con- 
trast microscopy (Fig. 5 C). At the standard concentrations 
used for microinjection (0. 3-0.5 mg/ml), no detectable alter- 
ations in the endogenous keratin IF networks were seen (Fig. 
5, D  and E). Interestingly, incorporation into the endoge- 
nous tonofilaments appeared to occur at a faster rate when 
lower concentrations of keratin were injected. Changes in 
keratin organization induced by injection of type I keratin at 
the highest concentrations were not fatal. Injected cells fully 
recovered and assembled a normal appearing keratin IF net- 
work over 24-36 h and frequently divided to produce daugh- 
ter cells, each containing extensive networks detected with 
anti-biotin which were coincident with the endogenous net- 
works as detected by double label immunofluorescence (Fig. 
6, A and B). 
To eliminate the possibility that the biotinylation of type 
I keratin might be involved in the alteration of the endoge- 
nous network, 1.5 mg/mi of non-biotinylated type I keratin 
was injected into PtK2 cells.  1-3  h  later,  cells were fixed 
and stained for immunofluorescence using anti-keratin 8 to 
visualize the endogenous keratin IF network. The endoge- 
nous network was disrupted in a fashion identical to that seen 
in cells injected with biotinylated keratin (see Fig. 5 B, data 
not shown). No alteration of  the endogenous keratin network 
could be  detected  1-4  h  after the microinjection of non- 
biotinylated keratin at lower concentrations (0.3-0.5 mg/ml) 
(data not shown). 
We also tested whether or not the more generalized effects 
of high concentrations of microinjected protein might be 
responsible for altering the endogenous IF network. To this 
end, we injected solutions containing high concentrations of 
biotinylated BSA (8 mg/ml). Cells were fixed and stained at 
time intervals after injection with anti-biotin and anti-keratin 
antibodies. Biotinylated BSA was found distributed diffusely 
throughout the cell with no obvious association with the en- 
dogenous keratin network, which appeared normal and un- 
disturbed (data not shown). 
The Type I-7ype H Complexes Formed 
Immediately after Microinjection Are Associated 
with Endogenous Tonofilaments 
A morphometric analysis was carried out to determine the 
relationship of the rapidly formed type I-type II aggregates 
(fluorescent spots)  and the endogenous keratin IF network 
using double label indirect immunofluorescence with anti- 
biotin and the anti-keratin antibody. In cytoplasmic regions 
containing well defined keratin IF networks, biotinylated 
spots were traced onto clear plastic and overlaid onto the 
corresponding keratin IF network. 2,861  spots were scored 
as either associated or not associated with tonofilaments. A 
large fraction (88 +  4%) of the biotinylated spots appeared 
in close association with the endogenous keratin IF network. 
Of those associated with tonofilaments, almost half were lo- 
cated near apparent branch points.  A  confocal-generated 
overlay of biotinylated spot association with tonofilaments is 
shown (Fig. 7). 
Figure 5. High concentrations of injected biotinylated type I keratin can alter the endogenous keratin IF network, while low concentrations 
do not. PtK2 cells were injected with high concentrations (1.5-2 mg/ml, A, B, and C) and the normal, low concentration (0.3-0.5 mg/ml, 
D and E) of biotinylated type I keratin. Cells were fixed 2 h postinjection and stained with anti-biotin (A and D) and anti-keratin 8 (B 
and E). A phase contrast micrograph of A, B is shown in C. Bar, 20 tim. 
Miller et al. Dynamic Properties  of Keratin Intermediate Filaments  129 Figure 6. Altered keratin IF networks recover. PtK2 were microinjected with high concentrations of biotinylated type I keratin and fixed 
after 24-36 h (A and B). Cells were stained with anti-biotin (A) and anti-keratin (B) antibodies. Bar, 10 #m. 
Immunogold Localization 
To determine the ultrastructural features of the fluorescent 
spots, their association with the IF bundles, and the general 
features of the  incorporation process,  an  electron micro- 
scopic analysis was carried out. Small subconfluent groups 
of PtK2 cells on locator coverslips were microinjected. At 
different  time  points,  coverslips  were  processed  for  im- 
munogold EM using an anti-biotin antibody and 5 nm gold 
conjugated secondary antibody. At 20 min, anti-biotin stain- 
ing revealed gold-labeled keratin aggregates that appeared 
Figure 7. A confocal generated overlay showing the association of 
biotinylated type I spots with the endogenous network. Ceils were 
microinjeeted with biotinylated type I keratin. After 20 min ceils 
were fixed and stained with anti-biotin (yellow~orange) and anti- 
keratin (green). Images were overlaid using the capabilities of the 
Zeiss confocal microscope and are displayed in pseudocolor. Bar, 
5 #m. 
electron dense and slightly granular. These were frequently 
found in close association with the apparent branch points 
of the IF bundles which comprise tonofilaments (Fig. 8 A). 
No obvious IF or protofilamentous structures were seen in 
any of the aggregates examined up to 25 min after microin- 
jection (Fig. 8 D). The peripheral gold labeling of the keratin 
aggregates was most likely the result of the pre-embedment 
labeling technique which probably inhibits antibody pene- 
tration into these densely packed proteinaceous structures. 
While at 20 min very little gold localization was detected 
along IF bundles, by 30-40 min after injection short seg- 
ments of tonofilaments were found labeled with gold in addi- 
tion to dense aggregates (Fig. 8 B). By 4-5 h, gold particles 
were found exclusively along tonofilaments and no dense ag- 
gregates could be detected (Fig.  8  C).  A  view at higher 
magnification is seen in Fig.  8 E.  No gold particles were 
found  associated  with  microfilaments,  microtubules,  or 
most other elements of the cytoplasm. However, some gold 
particles were found located within mitoehondria (data not 
shown), confirming that the weak background staining previ- 
ously  observed  with  anti-biotin  by  indirect  immunofluo- 
rescence (57) was due to endogenous biotin normally asso- 
ciated  with  mitochondrial  functions.  At  all  time  points, 
control preparations of uninjected cells showed no labeling 
of IF bundles. 
Discussion 
Immediately after microinjection, biotinylated type I bovine 
keratin forms aggregates in close association with the keratin 
containing  tonofilaments.  It  then  appears  to  become  in- 
tegrated into the endogenous keratin IF network at numerous 
sites (57). The biotinylated type I aggregates are seen to con- 
tain endogenous type II keratin within less than a minute af- 
ter injection.  Furthermore, at high concentrations, the in- 
jected type I keratin has a disruptive effect  on the endogenous 
keratin IF network. Our results are consistent with a model 
of keratin IF as dynamic cytoskeletal elements capable of 
continual subunit exchange processes. 
1j~pe I-Ij~pe H Complexes Form Rapidly 
Numerous studies indicate that keratin IF assembly involves 
the formation of type I and type II keratin heterodimers (15, 
The Journal of Cell Biology,  Volume  122, 1993  130 Figure  8.  Immunogold localization showing biotinylated keratin incorporation into tonofilaments. PtK2 cells were injected with bio- 
tinylated type I keratin and fixed after 20 min (A and D), 30-40 min (B), and 5 h (C and E). Samples were probed with goat anti-biotin 
and gold-conjugated rabbit anti-goat secondary antibody and embedded for EM. Higher magnification views of the areas marked by the 
rectangles in A and C are seen in D  and E, respectively, rot,  microtubule. Bars, 200 nm. 
Miller et al. Dynamic Properties of Keratin Intermediate Filaments  131 Figure 9. A possible model explaining the behavior of keratin IF in cells injected with biotinylated type I keratin. Keratin IF are comprised 
of heterodimers  containing type I (shown with white globular end domains) and type II (shown with gray globular domains) keratin (37, 
74). In this model, dimers (or higher-order oligomers) can exit keratin IF polymers (seen at top and bottom), and either re-enter the polymer 
directly  or dissociate transiently  into monomers.  After injection,  biotinylated type I keratin (shown in black) can pair with monomeric 
endogenous type II keratin.  This heterologous dimer can then enter a pre-existing  10 nm keratin IF. Since the data derived from FRAP 
experiments on vimentin-IF in vivo strongly suggest that subunit exchange can occur all along the length of vimentin IF (86), this model 
has been drawn to follow that paradigm. While the steady-state equilibrium is likely to lie in the direction of the more polymerized forms 
(as indicated by the arrows), the addition of a large concentration of exogenous type I keratin chains will likely shift the steady state equilib- 
rium. This would result in additional subunits being withdrawn from the polymer, and an increased rate of  dimer to monomer dissociation. 
In turn, this could cause alterations to the endogenous network as seen at the high concentrations  of microinjeeted keratin. 
Several additional parameters must also be considered within the context of  this model. For example, the fate of  the displaced endogenous 
type I keratin is not known. However, homodimers have been shown to assemble into urea-cycled keratin IF in vitro (74). Similar incorpora- 
tion in vivo could contribute to the experimental  observations and is shown by the incorporation  of a biotinylated homodimer (depicted 
in black).  Another consideration is based on the finding that unpaired keratins can be degraded  (21, 48, 49, 52). However, the extent of 
degradation of the excess type I keratin would be difficult to determine  in microinjected cells. 
37, 54, 74, 79).  The finding that the type II keratin specific 
antibody, AE3, stains the same spots formed by the microin- 
jetted biotinylated type I protein lends further support to the 
idea of heterodimer formation in vivo. Although higher or- 
der associations cannot be ruled out using our methods, the 
association of injected biotinylated type I with endogenous 
type II probably involves the dimerization step described in 
numerous studies in vitro (15, 37, 74). Our results also sug- 
gest that type I-type II associations take place before incor- 
poration into pre-existing tonofilaments. 
The "Capture" of  Endogenous 13ype  H Keratin 
within the Spots Suggests That Keratin Subunits 
Can Be Rapidly Mobilized 
FRAP  studies  of  vimentin  IF  have  supported  the  exis- 
tence  of  a  soluble  pool  which  provides  the  underlying 
mechanism for a steady state exchange between subunit and 
polymer, permitting a bleached zone to recover its fluores- 
cence along the length of a vimentin fiber (86).  In support 
of this, cell fractionation studies have shown that there is a 
small soluble pool of vimentin IF in vivo (6,  71) and that 
newly synthesized vimentin (6) and neurotilament proteins 
(5)  are  rapidly  transferred  through  this  soluble  pool to  a 
pelletable cytoskeletal fraction. However, the existence of a 
similar pool of keratin subunits has not been characterized. 
Therefore the association of type II keratin within the ag- 
gregates of the biotinylated keratin suggests that the injected 
protein "captures" endogenous subunits before its incorpora- 
tion into the IF comprising tonofilaments. This association 
occurs rapidly, within less than 1 rain after injection, and re- 
quires that endogenous type II keratin is available for such 
complex formation, moving from its native state within the 
cell to the biotinylated type I aggregates. Therefore, the type 
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that found in the fully polymerized keratin IF comprising 
tonofilaments and another in a pool, albeit most likely very 
small,  not associated with tonofilaments. Considering the 
speed with which type 1I associates with the spots, it is possi- 
ble that this association takes place during the process of spot 
formation. It is unlikely that the endogenous type II keratin 
is cotranslationally associated with the spots.  In support of 
this, type I keratin can form extensive networks after injec- 
tion into PtK~ cells in the absence of protein synthesis (57). 
Therefore, the incorporation of exogenous subunits into the 
endogenous polymerized keratin IF network is a dynamic 
process  (57)  reflecting a  surprisingly high rate of subunit 
mobility in vivo. 
Models of Dynamic Equilibrium 
As indicated above, the rapid formation of aggregates con- 
taining both type I and II keratins suggests the availability in 
vivo of unpolymerized type II keratin. This pool could con- 
sist of type 1I protein available in the cytosolic compartment 
and/or it could be derived from polymerized IF as depicted 
in Fig. 9. This model is based on the existence of an equilib- 
rium state in vivo.  As a result injected type I keratin could 
pair with endogenous type II keratin, forming heterodimers. 
Once formed, dimers can subsequently re-enter the keratin 
polymer. As the concentration of biotinylated type I is in- 
creased,  additional keratin subunits are drawn out of the 
polymer, resulting ultimately in a more significant shift in 
the equilibrium such that more type II subunits enter the 
"pool: Therefore, above a  certain concentration of excess 
type I, the model would predict structural changes and disas- 
sembly of the endogenous keratin tonofilament network. In 
support of this latter contention, changes in the assembly 
state of the endogenous keratin IF network were seen when 
the highest concentrations of  type I protein were injected and 
monitored by the immunofluorescence methods used in this 
study. 
It must be kept in mind that homodimers have been shown 
to become incorporated into keratin IF to a limited extent 
in vitro (37, 74,  75).  This possibility is also shown in the 
model depicted in Fig. 9. The alteration of the endogenous 
network may also be due in part to an incorporation into the 
network of an excess of such homodimers (37, 74).  These 
could be formed either by biotinylated type I homodimers, 
biotinylated type I-endogenous type I keratin (heterologous 
homodimers),  or  endogenous  type I  homodimers  which 
might be more likely to form if their type II partner has been 
sequestered by an excess of biotinylated type I keratin. The 
observation that the microinjection of lower concentrations 
of type I keratin seemed to incorporate faster than higher 
concentrations could also be explained by this model. Our 
results are consistent with the in vitro models of keratin as- 
sembly compiled by Coulombe and Fuchs (15). 
Even at the highest concentrations of injected protein, the 
disrupted keratin network ultimately recovers its normal or- 
ganization demonstrating that this type of alteration is not le- 
thal to the cell. It is possible that the cell has restored the 
unbalanced equilibrium caused by microinjection, perhaps 
through new protein synthesis. It further suggests that the 
cell is capable of a continual remodeling of its keratin IF net- 
work in response to intracellular shifts in the concentrations 
of a specific type of keratin. 
It is possible that alterations seen in the endogenous net- 
work using high concentrations may also be the result of 
titrating out not only the type II keratin partner from existing 
"pools; but may also result from altering the endogenous 
stoichiometric relationships among other factors important 
for keratin IF assembly. These might include keratin IF as- 
sociated proteins, kinases, phosphatases, or other unknown 
elements involved in IF assembly (26, 69). Whatever the ex- 
planation, the alterations seen following the addition of only 
one keratin underscore the importance of maintaining cor- 
rect stoichiometric relationships amongst all of the molecu- 
lar constituents regulating the organization of IF networks. 
This concept can also be extended to the interpretation of 
stable or transient transfection results in which the levels of 
expression of the desired gene product have not been or can- 
not be adequately controlled or measured. In support of this, 
similar results have also been obtained in transient transfec- 
tion experiments: the same mutant keratin construct trans- 
fected into PtK2 cells caused more severe disruption of the 
keratin IF network than when expressed in SCC-13  cells 
which contain more total keratin (53). 
Previous work has demonstrated that the products of sin- 
gle transfected keratin genes are rapidly degraded when ex- 
pressed in fibroblasts, whereas the pair-wise expression of a 
type I and a type II keratin results in resistance to proteoly- 
sis.  These observations suggested that specific proteolysis 
may represent a cellular mechanism for the maintenance of 
equimolar ratios of type I/type II keratin within the cell (21, 
48, 49,  54).  Consistent with these findings, we have found 
that type I keratin is no longer detectable by immunofluores- 
cence 24 hours after microinjection into BHK-21 fibroblasts. 
The finding that type II colocalizes with the type I in the spot 
stage in epithelial cells immediately following injection may 
therefore represent an interesting correlate of the observa- 
tions made in genetically engineered ceils. 
By EM, the spots formed immediately following microin- 
jection into PtK~ cells exhibit an electron-dense, granular 
appearance. They do not appear to contain protofilamentous 
structures seen in the type III IF protein aggregates which 
form following the breakdown of IF during the prometa- 
phase-metaphase transition in BHK-21  fibroblasts (66) and 
the similar keratin-rich aggregates reported in some types of 
epithelial cells in mitosis (28).  Frequently, the spots appear 
to associate with apparent branch points of the network by 
both light and electron microscopic criteria. Although the 
significance of this latter observation is not yet apparent, it 
is tempting to speculate that preferential incorporation may 
be occurring in these regions. However, the molecular mech- 
anisms underlying the formation of these foci remains un- 
known. 
The keratins exhibit an extensive array of  posttranslational 
modifications,  including  phosphorylation  (73),  disulfide 
bonding (68, 76), e-(g-glutamyl)-lysine  cross-links (76), and 
glycosylation (13). While the posttranslational modifications 
of acetylation and detyrosination of tubulin are believed to 
confer stability to microtubules (55),  little is known con- 
cerning the role which such modifications play in regulating 
the dynamic properties of IF. Microinjection techniques now 
provide  an  avenue  to  test  directly  the  role  that  these 
modifications play in the dynamics and assembly processes 
of keratin IF networks in vivo. 
In summary, we present evidence consistent with the exis- 
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polymerized keratin IF in epithelial cells. It appears that this 
equilibrium state provides a "soluble pool" of keratin which 
contributes  to  the  initial  steps  in  the  incorporation  of 
microinjected  keratin  subunits  into  polymerized  IE  The 
speed at which the initial steps in this assembly process takes 
place is remarkably  rapid and provides further proof that IF 
are  dynamic  elements  of the  cytoskeleton  of mammalian 
cells. 
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